![Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 | Journal of Medicinal Chemistry Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm500871s/asset/images/medium/jm-2014-00871s_0002.gif)
Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 | Journal of Medicinal Chemistry
![Giorgio INGHIRAMI | Professor, Director of Immunopathology Laboratory | Professor of Pathology and Laboratory Medicine | Weill Cornell Medical College, NY | Cornell | Department of Pathology and Laboratory Medicine | Research profile Giorgio INGHIRAMI | Professor, Director of Immunopathology Laboratory | Professor of Pathology and Laboratory Medicine | Weill Cornell Medical College, NY | Cornell | Department of Pathology and Laboratory Medicine | Research profile](https://i1.rgstatic.net/ii/profile.image/288214301593601-1445727052829_Q512/Giorgio-Inghirami-2.jpg)
Giorgio INGHIRAMI | Professor, Director of Immunopathology Laboratory | Professor of Pathology and Laboratory Medicine | Weill Cornell Medical College, NY | Cornell | Department of Pathology and Laboratory Medicine | Research profile
Primera Nacional: #VillaDalmine buscará extender su buen inicio de año frente a San Martín (T) - Noticias de Campana, La Auténtica Defensa
![LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE](https://www.eldebate.com.ar/wp-content/uploads/2020/07/LEANDRO1a.jpg)
LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE
Primera Nacional: #VillaDalmine visita esta tarde a Quilmes buscando volver a la victoria - Noticias de Campana, La Auténtica Defensa
![A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation | Leukemia A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fleu.2014.347/MediaObjects/41375_2015_Article_BFleu2014347_Fig1_HTML.jpg)
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation | Leukemia
![LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE](https://www.eldebate.com.ar/wp-content/uploads/2020/07/LEANDRO7a.jpg)
LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE
![Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 | Journal of Medicinal Chemistry Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm500871s/asset/images/large/jm-2014-00871s_0007.jpeg)
Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 | Journal of Medicinal Chemistry
Bisubstrate-Type Chemical Probes Identify GRP94 as a Potential Target of Cytosine-Containing Adenosine Analogs | ACS Chemical Biology
![LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE](https://www.eldebate.com.ar/wp-content/uploads/2020/07/LEANDRO2a.jpg)
LEANDRO CERCHIETTI: El médico zarateño que triunfa en los EE. UU. sigue dando pasos importantes en materia de investigación oncológica | EL DEBATE
![Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma | Nature Communications Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncomms4904/MediaObjects/41467_2014_Article_BFncomms4904_Fig1_HTML.jpg)